These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 7252794)

  • 1. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.
    Riegelman S; Collier P
    J Pharmacokinet Biopharm; 1980 Oct; 8(5):509-34. PubMed ID: 7252794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.
    Brockmeier D
    Arzneimittelforschung; 1984; 34(11):1604-7. PubMed ID: 6543138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation and estimates of mean residence time with statistical moment theory.
    Kasuya Y; Hirayama H; Kubota N; Pang KS
    Biopharm Drug Dispos; 1987; 8(3):223-34. PubMed ID: 3593900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
    Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
    Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical moments in pharmacokinetics.
    Yamaoka K; Nakagawa T; Uno T
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):547-58. PubMed ID: 731417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mean dissolution time depends on the dose/solubility ratio.
    Rinaki E; Dokoumetzidis A; Macheras P
    Pharm Res; 2003 Mar; 20(3):406-8. PubMed ID: 12669960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion.
    Chan KK; Gibaldi M
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):551-8. PubMed ID: 7166738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of statistical moment parameters to Cmax and tmax for detecting differences in in vivo dissolution rates.
    Khoo KC; Gibaldi M; Brazzell RK
    J Pharm Sci; 1985 Dec; 74(12):1340-2. PubMed ID: 4087205
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of moment analysis in assessing rates of absorption for bioequivalency studies.
    Jackson AJ; Chen ML
    J Pharm Sci; 1987 Jan; 76(1):6-9. PubMed ID: 3585726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products.
    Tanigawara Y; Yamaoka K; Nakagawa T; Uno T
    J Pharm Sci; 1982 Oct; 71(10):1129-33. PubMed ID: 7143211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between drug input and mean residence time in the body.
    Bialer M; Look ZM; Silber BM; Yacobi A
    Biopharm Drug Dispos; 1986; 7(6):577-83. PubMed ID: 3828487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.
    Zhou R; Moench P; Heran C; Lu X; Mathias N; Faria TN; Wall DA; Hussain MA; Smith RL; Sun D
    Pharm Res; 2005 Feb; 22(2):188-92. PubMed ID: 15783065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.
    Chiou WL
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):539-46. PubMed ID: 731416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of mean residence time using statistical moments: it is correct.
    Gillespie WR; Veng-Pedersen P
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):549-54. PubMed ID: 3834068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A versatile computational method for the determination of areas under the curve and moment curve following multidose drug administration.
    Yamashita TS; Lee HL; Reed MD
    Int J Biomed Comput; 1988 Dec; 23(3-4):239-49. PubMed ID: 3225062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory.
    Chan KK
    Drug Metab Dispos; 1982; 10(5):474-9. PubMed ID: 6183086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC).
    Purves RD
    J Pharmacokinet Biopharm; 1992 Jun; 20(3):211-26. PubMed ID: 1522479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reaction limited in vivo dissolution model for the study of drug absorption: Towards a new paradigm for the biopharmaceutic classification of drugs.
    Macheras P; Iliadis A; Melagraki G
    Eur J Pharm Sci; 2018 May; 117():98-106. PubMed ID: 29425862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.